Drug Shortage Report for DEPAKENE
Report ID | 232045 |
Drug Identification Number | 00443832 |
Brand name | DEPAKENE |
Common or Proper name | VALPROIC ACID |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | VALPROIC ACID |
Strength(s) | 250MG |
Dosage form(s) | SOLUTION SOLUTION |
Route of administration | ORAL ORAL |
Packaging size | 240ML |
ATC code | N03AG |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-07-15 |
Actual start date | 2024-07-12 |
Estimated end date | 2024-08-02 |
Actual end date | 2024-08-06 |
Shortage status | Resolved |
Updated date | 2024-08-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2024-08-07 | English | Compare |
v10 | 2024-08-06 | French | Compare |
v9 | 2024-08-06 | English | Compare |
v8 | 2024-07-16 | French | Compare |
v7 | 2024-07-16 | English | Compare |
v6 | 2024-07-16 | English | Compare |
v5 | 2024-07-09 | French | Compare |
v4 | 2024-07-09 | English | Compare |
v3 | 2024-07-04 | English | Compare |
v2 | 2024-07-03 | French | Compare |
v1 | 2024-07-03 | English | Compare |
Showing 1 to 11 of 11